Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Repro-Med Systems, Inc. (KRMD)
:KRMD
Holding KRMD?
Track your performance easily
KRMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.98 - $4.60
Previous CloseN/A
Volume31.78K
Average Volume (3M)101.05K
Market Cap
$183.35M
Enterprise Value$120.61M
Total Cash (Recent Filing)$3.58M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.37
Next Earnings
Feb 26, 2025EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.26
Shares Outstanding45,837,303
10 Day Avg. Volume112,010
30 Day Avg. Volume101,051
Standard Deviation0.18
R-Squared0.02
Alpha0.00061
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)5.73
Price to Cash Flow (P/CF)-49.60
P/FCF Ratio0.00
Enterprise Value/Market Cap0.66
Enterprise Value/Revenue3.77
Enterprise Value/Gross Profit7.22
Enterprise Value/Ebitda-20.75
Forecast
1Y Price Target
$4.88Price Target Upside19.32% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
REPRO-MED Systems News
PremiumCompany Announcements
REPRO-MED Systems Releases Investor Presentation Online
PremiumCompany Announcements
KORU Medical Systems Reports Strong Q3 GrowthOwnership Overview
18.65% Insiders
5.04% Mutual Funds
0.15% Other Institutional Investors
72.27% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
KRMD FAQ
What was Repro-Med Systems, Inc.’s price range in the past 12 months?
Repro-Med Systems, Inc. lowest stock price was $1.98 and its highest was $4.60 in the past 12 months.
What is Repro-Med Systems, Inc.’s market cap?
Repro-Med Systems, Inc.’s market cap is $183.35M.
When is Repro-Med Systems, Inc.’s upcoming earnings report date?
Repro-Med Systems, Inc.’s upcoming earnings report date is Feb 26, 2025 which is in 39 days.
How were Repro-Med Systems, Inc.’s earnings last quarter?
Repro-Med Systems, Inc. released its earnings results on Nov 13, 2024. The company reported -$0.03 earnings per share for the quarter, beating the consensus estimate of -$0.039 by $0.009.
Is Repro-Med Systems, Inc. overvalued?
According to Wall Street analysts Repro-Med Systems, Inc.’s price is currently Undervalued.
Does Repro-Med Systems, Inc. pay dividends?
Repro-Med Systems, Inc. does not currently pay dividends.
What is Repro-Med Systems, Inc.’s EPS estimate?
Repro-Med Systems, Inc.’s EPS estimate is -0.03.
How many shares outstanding does Repro-Med Systems, Inc. have?
Repro-Med Systems, Inc. has 45,837,303 shares outstanding.
What happened to Repro-Med Systems, Inc.’s price movement after its last earnings report?
Repro-Med Systems, Inc. reported an EPS of -$0.03 in its last earnings report, beating expectations of -$0.039. Following the earnings report the stock price went down -3.75%.
Which hedge fund is a major shareholder of Repro-Med Systems, Inc.?
Currently, no hedge funds are holding shares in KRMD
---
REPRO-MED Systems Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$4.88 (19.32% Upside)
$4.88 (19.32% Upside)
Blogger Sentiment
Bullish
KRMD Sentiment 70%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
94.76%
12-Months-Change
Fundamentals
Return on Equity
-53.01%
Trailing 12-Months
Asset Growth
-22.53%
Trailing 12-Months
Company Description
Repro-Med Systems, Inc.
Repro-Med Systems, Inc.engages in the design, manufacture, and market of proprietary medical devices. It products include FREEDOM60, a syringe infusion pump, which is designed for ambulatory medication infusions; HIgH-Flo, is designed for self-administration of medicine under the skin; and RES-Q-VAC, is a portable and hand-operated suction device that removes fluids from a patients airway. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Chester, NY.
---
KRMD Company Deck
---
KRMD Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a strong performance in revenue growth, improved margins, and a robust pipeline in Novel Therapies. Despite some delays in product submissions, the company showed positive financial results and raised guidance, indicating confidence in future growth. The highlights significantly outweighed the lowlights.Read More>---
KRMD Stock 12 Month Forecast
Average Price Target
$4.88
▲(19.32% Upside)
Technical Analysis
Best Analysts Covering KRMD
1 Year
1 Year Success Rate
8/10 ratings generated profit
1 Year Average Return
+51.31%
reiterated a buy rating 3 days ago
Copying Frank Takkinen's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +51.31% per trade.
---